Shopping Cart
Remove All
Your shopping cart is currently empty
BI 703704, a soluble guanylate cyclase (sGC) activator, inhibits the progression of diabetic nephropathy in the ZSF1 rat [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | Inquiry | 3-6 months | 3-6 months | |
| 50 mg | Inquiry | 3-6 months | 3-6 months | |
| 100 mg | Inquiry | 3-6 months | 3-6 months |
| Description | BI 703704, a soluble guanylate cyclase (sGC) activator, inhibits the progression of diabetic nephropathy in the ZSF1 rat [1]. |
| In vivo | BI 703704 administered at dosages of 0.3 to 10 mg/kg through food intake daily for 15 weeks in fifty-eight male ZSF1 rats aged 12-13 weeks led to a dose-dependent reduction in urinary protein excretion (UPE) and a dose-dependent elevation in renal cGMP levels [1]. The compound effectively increases renal cGMP in a dose-responsive manner, thereby decelerating the progression of diabetic nephropathy under conditions of oxidative stress [1]. |
| Molecular Weight | 559.72 |
| Formula | C32H37N3O4S |
| Cas No. | 2740807-77-4 |
| Smiles | O(CC1=C(C)C=C(C(=O)N2CCCCC2)C=C1)C3=C(C=C(C)C=C3)C=4N=C(SC4)N5C[C@]6([C@@H](C(O)=O)[C@@](C5)(CC6)[H])[H] |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.